elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50042993-3C50F0B8-0469-4B09-8341-26FC42748442
Q50042993-3C50F0B8-0469-4B09-8341-26FC42748442
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50042993-3C50F0B8-0469-4B09-8341-26FC42748442
Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia.
P2860
Q50042993-3C50F0B8-0469-4B09-8341-26FC42748442
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50042993-3C50F0B8-0469-4B09-8341-26FC42748442
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa000e09b8223799bc7cce55b99bfd5513feeacc
P2860
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.